What LabCorp's Earnings Mean For Mutual Fund Investors (LH)

Welcome to MutualFunds.com

Please help us personalize your experience and select the one that best describes you.

Your personalized experience is almost ready.

Join other Individual Investors receiving FREE personalized market updates and research. Join other Institutional Investors receiving FREE personalized market updates and research. Join other Financial Advisors receiving FREE personalized market updates and research.

Thank you!

Check your email and confirm your subscription to complete your personalized experience.

Thank you for your submission

We hope you enjoy your experience

Channels

Fixed income news, reports, video and more.

Municipal bonds news, reports, video and more.

Practice management news, reports, video and more.

Portfolio management news, reports, video and more.

Retirement news, reports, video and more.

Learn from industry thought leaders and expert market participants.

Find the latest content and information here about the 2019 Charles Schwab Impact Conference.

Advisors

Receive email updates about fund flows, news, upcoming CE accredited webcasts from industry thought leaders and more.

Content focused on helping financial advisors build successful client relationships and grow their business.

Content geared towards helping financial advisors build better client portfolios.

Get insights on the industry trends and investment news from leading fund managers and experts.

What LabCorp's Earnings Mean For Mutual Fund Investors (LH)

Laboratory Corp. of America Holdings
Before the opening bell on Monday, LabCorp (LH) released its first quarter financial results. Here’s what the results mean for mutual fund investors.

Inside LH’s Result

Earnings

The company reported earnings of $0.7 million, or 1 cent per share, down from $113.1 million, or $1.31 per share, last year. Adjusted earnings came in at $1.73 per share, above analysts’ view of $1.63.

Revenue
Revenue increased to $1.79 billion from $1.43 billion last year. Analysts expected to see revenue of $1.79 billion.

Acquisition Charges

The company reported that its first quarter profits took a hit due to restructuring and acquisition charges. The company recently closed a $5.7 billion deal to acquire drug company Covance. This purchase is one of many for LabCorp, which has been growing its business and benefiting from the transactions.

Mutual Funds to Watch

Investors interested in LH may be interested in the funds listed below. These funds currently have the largest stakes in the company.

The Bottom Line

The funds listed above allow investors to gain exposure to LH while remaining diversified. Investors interested in LH may also be interested in Quest Diagnostics (DGX).

Sign up for Advisor Access

Receive email updates about best performers, news, CE accredited webcasts and more.

Popular Articles

Download our free report

Find out why $30 trillon is invested in mutual funds.

Why 30 trillion is invested in mutual funds book

Why 30 trillion is invested in mutual funds book

Download our free report

Find out why $30 trillon is invested in mutual funds.

Why 30 trillion is invested in mutual funds book

Download our free report

Find out why $30 trillon is invested in mutual funds.


Read Next

Laboratory Corp. of America Holdings

What LabCorp's Earnings Mean For Mutual Fund Investors (LH)

Before the opening bell on Monday, LabCorp (LH) released its first quarter financial results. Here’s what the results mean for mutual fund investors.

Inside LH’s Result

Earnings

The company reported earnings of $0.7 million, or 1 cent per share, down from $113.1 million, or $1.31 per share, last year. Adjusted earnings came in at $1.73 per share, above analysts’ view of $1.63.

Revenue
Revenue increased to $1.79 billion from $1.43 billion last year. Analysts expected to see revenue of $1.79 billion.

Acquisition Charges

The company reported that its first quarter profits took a hit due to restructuring and acquisition charges. The company recently closed a $5.7 billion deal to acquire drug company Covance. This purchase is one of many for LabCorp, which has been growing its business and benefiting from the transactions.

Mutual Funds to Watch

Investors interested in LH may be interested in the funds listed below. These funds currently have the largest stakes in the company.

The Bottom Line

The funds listed above allow investors to gain exposure to LH while remaining diversified. Investors interested in LH may also be interested in Quest Diagnostics (DGX).

Sign up for Advisor Access

Receive email updates about best performers, news, CE accredited webcasts and more.

Popular Articles

Download our free report

Find out why $30 trillon is invested in mutual funds.

Why 30 trillion is invested in mutual funds book

Why 30 trillion is invested in mutual funds book

Download our free report

Find out why $30 trillon is invested in mutual funds.

Why 30 trillion is invested in mutual funds book

Download our free report

Find out why $30 trillon is invested in mutual funds.


Read Next